One patient claims he lost his vision due to Ozempic.
He took Ozempic to manage his diabetes. A few months later, he says he lost his eyesight and lost his job. He is currently suing over what he claims happened.
Ashley Graham has a bone to pick with GLP-1. Specifically, how we’re bringing a new wave of thinness back to the runways.
“I was really disappointed,” the 38-year-old model recently told Marie Claire. “The pendulum has swung back towards body acceptance, positivity, and everyone being able to be who they want to be. And now it’s swinging back in the exact opposite direction, and for women who felt like they’ve been given a voice, it feels like a slap in the face.”
GLP-1 injections can be a life-changing tool for those who need them, offering significant health benefits, especially for people with diabetes. Approximately 1 in 8 adults in the United States has used it for diabetes, heart disease, or weight loss. But with FDA-approved weight loss drugs now on the market, some mental health and eating disorder experts worry that the proliferation of these drugs is a throwback to the ubiquitous days of diet culture, and that people with a history of eating disorders will seek out GLP-1 in pill form as it becomes the cultural norm.
But that doesn’t mean progress is over and we’ll never see plus-size models again. “It’s with the times and GLP-1 is with the times…We know there have been and will always be women who will be considered plus size forever,” Graham added. “This drug won’t completely erase the statistics for women.”
Graham continued, “There’s a lot of[plus-size influencers and creators]… They’re all over the place because of their size and their proportions and their appearance and their relatability. And to me, that’s the coolest part of all of this. It bothers me that these girls who grew up on social media from a young age are now here and have a platform to say to the younger generation, ‘Be yourself, be who you want to be. If you have cellulite, who?'”
Contributor: Sara Moniuszko
